[Prophylaxis of fungal infections in haematological patients: contra].
Schwartz
S
S
Medizinische Klinik III, Charité -Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin. stefan.schwartz@charite.de
D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D002986:Clinical Trials as Topic; D025141:Drug Resistance, Fungal; D019337:Hematologic Neoplasms / Q000150:complications* / Q000401:mortality / Q000628:therapy*; D006801:Humans; D009181:Mycoses / Q000401:mortality / Q000517:prevention & control*; D009503:Neutropenia / Q000150:complications; D009894:Opportunistic Infections / Q000401:mortality / Q000517:prevention & control*; D012307:Risk Factors; D015996:Survival Rate; D016896:Treatment Outcome
D000935:Antifungal Agents